North Star Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

North Star Investment Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Hold	13	–	–	﹤0.01%	1410
2026 Q1	$1.71K	Hold	13	–	–	﹤0.01%	1429
2025 Q4	$1.84K	Hold	13	–	–	﹤0.01%	1341
2025 Q3	$1.82K	Hold	13	–	–	﹤0.01%	1128
2025 Q2	$1.63K	Hold	13	–	–	﹤0.01%	1107
2025 Q1	$1.44K	Hold	13	–	–	﹤0.01%	1108
2024 Q4	$1.77K	Hold	13	–	–	﹤0.01%	1124
2024 Q3	$1.5K	Hold	13	–	–	﹤0.01%	1105
2024 Q2	$1.79K	Hold	13	–	–	﹤0.01%	1046
2024 Q1	$1.79K	Hold	13	–	–	﹤0.01%	1098
2023 Q4	$1.71K	Hold	13	–	–	﹤0.01%	1060
2023 Q3	$1.46K	Hold	13	–	–	﹤0.01%	1092
2023 Q2	$1.23K	Hold	13	–	–	﹤0.01%	1130
2023 Q1	$1.32K	Hold	13	–	–	﹤0.01%	1130
2022 Q4	$1.55K	Hold	13	–	–	﹤0.01%	1112
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	1085
2022 Q2	$1K	Hold	13	–	–	﹤0.01%	1089
2022 Q1	$1K	Hold	13	–	–	﹤0.01%	1107
2021 Q4	$1K	Hold	13	–	–	﹤0.01%	1135
2021 Q3	$1K	Hold	13	–	–	﹤0.01%	1084
2021 Q2	$1K	Hold	13	–	–	﹤0.01%	1060
2021 Q1	$1K	Hold	13	–	–	﹤0.01%	1023
2020 Q4	$1K	Hold	13	–	–	﹤0.01%	997
2020 Q3	$1K	Buy	+13	New	+$1.5K	﹤0.01%	978

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

North Star Investment Management's NBIX Position: Q2 2026 in Review

North Star Investment Management held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 13 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

North Star Investment Management first reported a position in NBIX in Q3 2020 and has held it in 24 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

North Star Investment Management held 13 shares of Neurocrine Biosciences worth $2.19K as of Q2 2026.
North Star Investment Management left its Neurocrine Biosciences share count unchanged in Q2 2026.
Neurocrine Biosciences made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1410 holding.
North Star Investment Management first reported a position in Neurocrine Biosciences in Q3 2020 and has held it in 24 quarters since.
781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.